Vitreoretinal Surgery Devices Market Analysis And Forecast To 2031: By Product (Photocoagulation Lasers, Illumination Devices, Vitreoretinal Packs, Vitrectomy Machines, Vitrectomy Probes), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgery Cente

Vitreoretinal Surgery Devices Market Analysis And Forecast To 2031: By Product (Photocoagulation Lasers, Illumination Devices, Vitreoretinal Packs, Vitrectomy Machines, Vitrectomy Probes), By End-use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers), And Region

The global vitreoretinal surgery devices market was valued at USD 1.7 Billion in 2021 and it is anticipated to grow up to USD 2.5 Billion by 2031, at a CAGR of 3.9% during the forecast period.

Vitreoretinal surgery devices are used to treat conditions of the retina and vitreous, the clear, jelly-like substance that fills the inside of the eye. There are a variety of vitreoretinal surgery devices, including: Retinal detachment repair devices: These devices are used to repair a retina that has become detached from the back of the eye. Retinal detachment is a serious condition that can lead to blindness. Vitrectomy devices: These devices are used to remove the vitreous from the eye. Vitrectomy is often performed to treat conditions such as diabetic retinopathy and macular degeneration. Retinal prosthesis: A retinal prosthesis is an artificial device that is implanted in the eye to replace the function of the retina. Retinal prostheses are used to treat conditions such as retinitis pigmentosa and age-related macular degeneration.
Global Vitreoretinal Surgery Devices Market Scope and Report Structure
[table id=593 /]
Market Trends and Drivers
The rapidly aging population is anticipated to spur the industry progression in the coming years. The WHO data estimates that the geriatric population is slated to double in the years from 2015 to 2050. The elderly population aged above 60 years is poised to showcase threefold growth during 2010 and 2050, reaching about 1.3 billion. Moreover, as per the United Nations Population Fund (UNFPA) estimates, by the year 2050, approximately 25% individuals in Asia Pacific region will be aged more than 60 years. Eye-related disorders are increasingly prevalent among the elderly population as aging affects vision and the ability to focus. The increasing elderly population affected with vision related conditions is set to fuel the vitreoretinal surgery devices market demand. The most frequent causes of vision impairment among the aging populace include the age-related macular degeneration, glaucoma, cataract, and diabetic retinopathy among others. Due to the increasing susceptibility and impaired vision, the prevalence of these disorders is commonly profound in people aged 60 and above.
Market Restraints and Challenges
Uncertain reimbursement scenario and high cost associated with the vitreoretinal surgery devices may negatively impact the market progression. The cost pertaining to the acquisition of vitreoretinal surgery devices may range from USD 5,000 to USD 15,000. The high cost associated with vitreoretinal surgery devices may limit the acceptance rate, thereby limiting the industry expansion. Owing to cost intensive nature of vitreoretinal surgeries, these medical procedures are reimbursed by the Medicare services. Despite of this reimbursement for the procedures, the reimbursement concerning vitreoretinal surgery devices is fairly uncertain that might restrict the industry demand.
Global Vitreoretinal Surgery Devices Market Segmental Overview
The report analyses the global vitreoretinal surgery devices market based on product, end-use, and region

Global Vitreoretinal Surgery Devices Market by Product

Based on product the market is segmented as Photocoagulation Lasers, Illumination Devices, Vitreoretinal Packs, Vitrectomy Machines, and Vitrectomy Probes. The photocoagulation lasers segment accounted for majority market share in 2021 and is anticipated to register a significant CAGR from 2022-20301. Photocoagulation lasers are applied in the treatment several eye disorders such the two leading causes of blindness in the U.S. including diabetic retinopathy and age-related macular degeneration. These precise laser-sourced devices reduce the risk of vision loss by cauterizing ocular blood vessels.

Global Vitreoretinal Surgery Devices Market by End-use

Based on end-use, the market is segmented as hospitals, specialty clinics, and ambulatory surgery centers. The ambulatory surgery centers. segment held substantial market share in 2021 and is anticipated to witness notable growth to reach highest market share and CAGR by 2031. This is owing wing to the growing number of vitreoretinal surgeries at ambulatory surgical centers. The increased usage of advanced and miniaturized vitreoretinal surgery devices reduced surgical time & increased convenience, and reduced instances of complications have minimized the requirement for hospitalization. Due to these developments, the number of vitreoretinal surgeries conducted in an outpatient setting has surged steadily that is expected to benefit the market share. In addition to this, the increasing pressure to minimize surging healthcare costs and availability of efficient equipment that limit the surgical complications including the reduced risks of catching the retina is further set to spur the industry demand.
Geographical Analysis of Global Vitreoretinal Surgery Devices Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America held substantial revenue share in 2021. High acceptance of advanced devices and the rise in incidence of eye-related disorders that translates to increased vitreoretinal surgeries across the country. For instance, according to the Centers for Disease Control & Prevention statistics, an estimated 20.5 million citizens in the U.S. aged 40 years and above were suffering with cataract in one or both eyes, and around 6.1 million Americans had their lens removed surgically. The overall number of individuals with cataracts was further projected to reach to 30.1 million by 2020. Similarly, approximately 1.8 million Americans aged 40 years and above were affected by age-related macular degeneration (AMD) and an additional 7.3 million Americans are at considerable risk of developing AMD. Such adverse conditions along with aging population are predicted to impel the adoption rate of vitreoretinal surgery devices in the country.
Major Players in the Global Vitreoretinal Surgery Devices Market
The key players in the market  Alcon, Inc., Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, MedOne Surgical, Inc., Carl Zeiss Meditec AG, Designs for Vision, Inc., Peregrine Surgical, D.O.R.C., Safilo Group, and Rodenstock, among others.
COVID-19 Impact
The COVID-19 pandemic has emerged as an unprecedented health concern that has rendered significant impact on the vitreoretinal surgery devices market value. The coronavirus outbreak has affected the global economy and several industrial structures including the healthcare sector. In order to minimize the further transmission of SARS-CoV-2 virus, national lockdowns were imposed, and emergencies were declared in several countries. Hospital admissions and services were offered to the COVID-19 affected patients on priority basis, with majority of the other medical procedures on halt. The U.S. declared a national emergency and postponed majority of the non-emergency surgical procedures in outpatient and inpatient settings. This has led to the delay in multiple medical procedures including vitreoretinal surgeries across various countries that has affected the market.
Recent Developments

In May 2021, MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low volume ophthalmic injections into the subretinal space.
In July 2020, Alcon to showcased latest innovations, data at American Society of Retina Specialists 2020 virtual annual meeting.
In May 2019, Hoya Surgical Optics completed the acquisition of Fritz Ruck and MID Labs. This acquisition will help Hoya in leveraging MID Lab’s vitrectomy cutters, machines, and other vitreoretinal surgical products, thus, contributing towards the expansion of its product portfolio.
In May 2019, Alcon launched advancements to the CENTURION® Vision System at American Society for cataract and refractive surgery meeting.

Vitreoretinal Surgery Devices Market Report Coverage

The report offers a comprehensive quantitative as well as qualitative analysis of the current global Vitreoretinal Surgery Devices Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
A thorough analysis of market trends and restraints is provided.
Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
The forecasts in this report are made by examining the recent trends along with future Vitreoretinal Surgery Devices Market potential from 2021 to 2031 in terms of revenue.
Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Vitreoretinal Surgery Devices Market are also analyzed.
Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Frequently Asked Questions
Q1. How big is the Vitreoretinal Surgery Devices Market?

Ans. The global Vitreoretinal Surgery Devices Market size was USD 1.7 Billion in 2021 and is anticipated to reach USD 2.5 Billion in 2031, growing at a rate of 3.9% from 2022 to 2031.

Q2. What is the Vitreoretinal Surgery Devices Market growth rate?

Ans. The growth rate of the Vitreoretinal Surgery Devices Market is 3.9%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Vitreoretinal Surgery Devices Market in 2021.

Q4. Which segment accounted for the largest Vitreoretinal Surgery Devices Market share?

Ans. By end-use, hospital segment accounted for the largest Vitreoretinal Surgery Devices Market share.

Q5. Who are the key players in the Clear Aligners Market?

Ans. The global Vitreoretinal Surgery Devices Market report includes players such  Alcon, Inc., Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, MedOne Surgical, Inc., Carl Zeiss Meditec AG, Designs for Vision, Inc., Peregrine Surgical, D.O.R.C., Safilo Group, and Rodenstock., among others.

Q6. What are the factors driving the Vitreoretinal Surgery Devices Market growth?

Ans. The major factors driving the growth of the market are significant advancements related to vitreoretinal surgery devices

Q7. What are the key growth strategies of Vitreoretinal Surgery Devices Market players?

Ans. The key growth strategies of Vitreoretinal Surgery Devices Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Vitreoretinal Surgery Devices Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Vitreoretinal Surgery Devices Market during the forecast period.The global vitreoretinal surgery devices market was valued at USD 1.7 Billion in 2021 and it is anticipated to grow up to USD 2.5 Billion by 2031, at a CAGR of 3.9% during the forecast period.

Vitreoretinal surgery devices are used to treat conditions of the retina and vitreous, the clear, jelly-like substance that fills the inside of the eye. There are a variety of vitreoretinal surgery devices, including: Retinal detachment repair devices: These devices are used to repair a retina that has become detached from the back of the eye. Retinal detachment is a serious condition that can lead to blindness. Vitrectomy devices: These devices are used to remove the vitreous from the eye. Vitrectomy is often performed to treat conditions such as diabetic retinopathy and macular degeneration. Retinal prosthesis: A retinal prosthesis is an artificial device that is implanted in the eye to replace the function of the retina. Retinal prostheses are used to treat conditions such as retinitis pigmentosa and age-related macular degeneration.
Global Vitreoretinal Surgery Devices Market Scope and Report Structure
[table id=593 /]
Market Trends and Drivers
The rapidly aging population is anticipated to spur the industry progression in the coming years. The WHO data estimates that the geriatric population is slated to double in the years from 2015 to 2050. The elderly population aged above 60 years is poised to showcase threefold growth during 2010 and 2050, reaching about 1.3 billion. Moreover, as per the United Nations Population Fund (UNFPA) estimates, by the year 2050, approximately 25% individuals in Asia Pacific region will be aged more than 60 years. Eye-related disorders are increasingly prevalent among the elderly population as aging affects vision and the ability to focus. The increasing elderly population affected with vision related conditions is set to fuel the vitreoretinal surgery devices market demand. The most frequent causes of vision impairment among the aging populace include the age-related macular degeneration, glaucoma, cataract, and diabetic retinopathy among others. Due to the increasing susceptibility and impaired vision, the prevalence of these disorders is commonly profound in people aged 60 and above.
Market Restraints and Challenges
Uncertain reimbursement scenario and high cost associated with the vitreoretinal surgery devices may negatively impact the market progression. The cost pertaining to the acquisition of vitreoretinal surgery devices may range from USD 5,000 to USD 15,000. The high cost associated with vitreoretinal surgery devices may limit the acceptance rate, thereby limiting the industry expansion. Owing to cost intensive nature of vitreoretinal surgeries, these medical procedures are reimbursed by the Medicare services. Despite of this reimbursement for the procedures, the reimbursement concerning vitreoretinal surgery devices is fairly uncertain that might restrict the industry demand.
Global Vitreoretinal Surgery Devices Market Segmental Overview
The report analyses the global vitreoretinal surgery devices market based on product, end-use, and region

Global Vitreoretinal Surgery Devices Market by Product

Based on product the market is segmented as Photocoagulation Lasers, Illumination Devices, Vitreoretinal Packs, Vitrectomy Machines, and Vitrectomy Probes. The photocoagulation lasers segment accounted for majority market share in 2021 and is anticipated to register a significant CAGR from 2022-20301. Photocoagulation lasers are applied in the treatment several eye disorders such the two leading causes of blindness in the U.S. including diabetic retinopathy and age-related macular degeneration. These precise laser-sourced devices reduce the risk of vision loss by cauterizing ocular blood vessels.

Global Vitreoretinal Surgery Devices Market by End-use

Based on end-use, the market is segmented as hospitals, specialty clinics, and ambulatory surgery centers. The ambulatory surgery centers. segment held substantial market share in 2021 and is anticipated to witness notable growth to reach highest market share and CAGR by 2031. This is owing wing to the growing number of vitreoretinal surgeries at ambulatory surgical centers. The increased usage of advanced and miniaturized vitreoretinal surgery devices reduced surgical time & increased convenience, and reduced instances of complications have minimized the requirement for hospitalization. Due to these developments, the number of vitreoretinal surgeries conducted in an outpatient setting has surged steadily that is expected to benefit the market share. In addition to this, the increasing pressure to minimize surging healthcare costs and availability of efficient equipment that limit the surgical complications including the reduced risks of catching the retina is further set to spur the industry demand.
Geographical Analysis of Global Vitreoretinal Surgery Devices Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America held substantial revenue share in 2021. High acceptance of advanced devices and the rise in incidence of eye-related disorders that translates to increased vitreoretinal surgeries across the country. For instance, according to the Centers for Disease Control & Prevention statistics, an estimated 20.5 million citizens in the U.S. aged 40 years and above were suffering with cataract in one or both eyes, and around 6.1 million Americans had their lens removed surgically. The overall number of individuals with cataracts was further projected to reach to 30.1 million by 2020. Similarly, approximately 1.8 million Americans aged 40 years and above were affected by age-related macular degeneration (AMD) and an additional 7.3 million Americans are at considerable risk of developing AMD. Such adverse conditions along with aging population are predicted to impel the adoption rate of vitreoretinal surgery devices in the country.
Major Players in the Global Vitreoretinal Surgery Devices Market
The key players in the market  Alcon, Inc., Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, MedOne Surgical, Inc., Carl Zeiss Meditec AG, Designs for Vision, Inc., Peregrine Surgical, D.O.R.C., Safilo Group, and Rodenstock, among others.
COVID-19 Impact
The COVID-19 pandemic has emerged as an unprecedented health concern that has rendered significant impact on the vitreoretinal surgery devices market value. The coronavirus outbreak has affected the global economy and several industrial structures including the healthcare sector. In order to minimize the further transmission of SARS-CoV-2 virus, national lockdowns were imposed, and emergencies were declared in several countries. Hospital admissions and services were offered to the COVID-19 affected patients on priority basis, with majority of the other medical procedures on halt. The U.S. declared a national emergency and postponed majority of the non-emergency surgical procedures in outpatient and inpatient settings. This has led to the delay in multiple medical procedures including vitreoretinal surgeries across various countries that has affected the market.
Recent Developments

In May 2021, MedOne Surgical announced the FDA 510(k) clearance of its MicroDose Injector device for low volume ophthalmic injections into the subretinal space.
In July 2020, Alcon to showcased latest innovations, data at American Society of Retina Specialists 2020 virtual annual meeting.
In May 2019, Hoya Surgical Optics completed the acquisition of Fritz Ruck and MID Labs. This acquisition will help Hoya in leveraging MID Lab’s vitrectomy cutters, machines, and other vitreoretinal surgical products, thus, contributing towards the expansion of its product portfolio.
In May 2019, Alcon launched advancements to the CENTURION® Vision System at American Society for cataract and refractive surgery meeting.

Vitreoretinal Surgery Devices Market Report Coverage

The report offers a comprehensive quantitative as well as qualitative analysis of the current global Vitreoretinal Surgery Devices Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
A thorough analysis of market trends and restraints is provided.
Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
The forecasts in this report are made by examining the recent trends along with future Vitreoretinal Surgery Devices Market potential from 2021 to 2031 in terms of revenue.
Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Vitreoretinal Surgery Devices Market are also analyzed.
Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Frequently Asked Questions
Q1. How big is the Vitreoretinal Surgery Devices Market?

Ans. The global Vitreoretinal Surgery Devices Market size was USD 1.7 Billion in 2021 and is anticipated to reach USD 2.5 Billion in 2031, growing at a rate of 3.9% from 2022 to 2031.

Q2. What is the Vitreoretinal Surgery Devices Market growth rate?

Ans. The growth rate of the Vitreoretinal Surgery Devices Market is 3.9%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Vitreoretinal Surgery Devices Market in 2021.

Q4. Which segment accounted for the largest Vitreoretinal Surgery Devices Market share?

Ans. By end-use, hospital segment accounted for the largest Vitreoretinal Surgery Devices Market share.

Q5. Who are the key players in the Clear Aligners Market?

Ans. The global Vitreoretinal Surgery Devices Market report includes players such  Alcon, Inc., Bausch & Lomb, Inc., OCULUS Optikgeräte GmbH, MedOne Surgical, Inc., Carl Zeiss Meditec AG, Designs for Vision, Inc., Peregrine Surgical, D.O.R.C., Safilo Group, and Rodenstock., among others.

Q6. What are the factors driving the Vitreoretinal Surgery Devices Market growth?

Ans. The major factors driving the growth of the market are significant advancements related to vitreoretinal surgery devices

Q7. What are the key growth strategies of Vitreoretinal Surgery Devices Market players?

Ans. The key growth strategies of Vitreoretinal Surgery Devices Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Vitreoretinal Surgery Devices Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Vitreoretinal Surgery Devices Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.